NUTF2 and breast carcinoma: Altogether, these results support a new EGFR–ERα signaling crosstalk mechanism in breast cancer cells, where EGFR signaling dissociates NUTF2 dimers and alters the PTM code to modulate ER signaling and cell growth, along with other critical drivers of cancer growth and metabolism.